AU6077599A - Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) - Google Patents
Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1)Info
- Publication number
- AU6077599A AU6077599A AU60775/99A AU6077599A AU6077599A AU 6077599 A AU6077599 A AU 6077599A AU 60775/99 A AU60775/99 A AU 60775/99A AU 6077599 A AU6077599 A AU 6077599A AU 6077599 A AU6077599 A AU 6077599A
- Authority
- AU
- Australia
- Prior art keywords
- improving
- mammalian cells
- genetic material
- gene transfer
- waf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to a method for stabilizing and improving the gene transfer of genetic material in mammalian cells, characterized in that the gene or its cDNA is expressed in the target cell with simultaneous expression of the cell cycle regulator p21, which prevents apoptosis.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19830874A DE19830874A1 (en) | 1998-07-10 | 1998-07-10 | Process for stabilizing and improving gene transfer from genetic material in mammalian cells |
DE19830874 | 1998-07-10 | ||
PCT/DE1999/002180 WO2000003027A1 (en) | 1998-07-10 | 1999-07-12 | Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6077599A true AU6077599A (en) | 2000-02-01 |
Family
ID=7873575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU60775/99A Abandoned AU6077599A (en) | 1998-07-10 | 1999-07-12 | Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1097234B1 (en) |
AT (1) | ATE292688T1 (en) |
AU (1) | AU6077599A (en) |
DE (2) | DE19830874A1 (en) |
WO (1) | WO2000003027A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19954444A1 (en) * | 1999-11-11 | 2001-05-31 | Theragen Molekularmedizinische | Method of protecting mammalian cells using overexpressed G-2 / M cell cycle couplers |
DE10015413A1 (en) * | 2000-03-23 | 2001-09-27 | Max Delbrueck Centrum | Composition for treating and diagnosing viral infections, caused by adenovirus, comprises an agent that modifies function of YB-1 protein, and YB-1 specific antibodies |
GB0113318D0 (en) * | 2001-06-01 | 2001-07-25 | Lonza Biologics Plc | Method for production of a protein |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863904A (en) * | 1995-09-26 | 1999-01-26 | The University Of Michigan | Methods for treating cancers and restenosis with P21 |
-
1998
- 1998-07-10 DE DE19830874A patent/DE19830874A1/en not_active Withdrawn
-
1999
- 1999-07-12 WO PCT/DE1999/002180 patent/WO2000003027A1/en active IP Right Grant
- 1999-07-12 AT AT99947210T patent/ATE292688T1/en not_active IP Right Cessation
- 1999-07-12 AU AU60775/99A patent/AU6077599A/en not_active Abandoned
- 1999-07-12 DE DE59911877T patent/DE59911877D1/en not_active Expired - Fee Related
- 1999-07-12 EP EP99947210A patent/EP1097234B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE19830874A1 (en) | 2000-01-13 |
EP1097234B1 (en) | 2005-04-06 |
DE59911877D1 (en) | 2005-05-12 |
EP1097234A1 (en) | 2001-05-09 |
ATE292688T1 (en) | 2005-04-15 |
WO2000003027A1 (en) | 2000-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU560340B2 (en) | Rennin from recombinant dna | |
WO1998020145A3 (en) | Improvements in or relating to starch content of plants | |
MX9606476A (en) | The cytoplasmic inhibition of gene expression. | |
MX9705039A (en) | Programmed cell death genes and proteins. | |
AU6131086A (en) | Epithelial cells expressing foreign genetic material | |
AU4336499A (en) | Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells | |
BR0012099A (en) | Cytoplasmic transfer to de-differentiate recipient cells | |
WO2001051616A3 (en) | Techniques for growth and differentiation of human pluripotent stem cells | |
AU1926899A (en) | Exploiting genomics in the search for new drugs | |
HK1091228A1 (en) | Methods for making recombinant proteins using apoptosis inhibitors | |
ES2255281T3 (en) | OVEREXPRESSION OF FITASA GENES IN SISTMAS DE LEVADURA. | |
MX9800499A (en) | Inhibition of gene expression. | |
IL117425A0 (en) | Receptor activation by gas6 | |
BR9712942A (en) | Method for the production of glycerol, transformed host cell, method for the selection of gene expression, strain pah21 / dh5x of escherichia coli and strain pah21 / dh5x of escherichia coli. | |
MX9800500A (en) | Inhibition of gene expression. | |
CA2250693A1 (en) | Compositions and methods for taxol biosynthesis | |
WO1998037185A3 (en) | Vectors for controlled gene expression | |
AU6077599A (en) | Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) | |
AUPN896596A0 (en) | Therapeutic molecules | |
EP0808364A4 (en) | Human pancreatic cell lines: developments and uses | |
DE69515652D1 (en) | USE OF DNA OLIGOMERS TO INHIBIT HIV BY REDUCING RIBOSOMAL READER COATING | |
AU1814995A (en) | Galanin receptor, nucleic acids, transformed cells and uses thereof | |
WO2000006713A8 (en) | Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin | |
PL354747A1 (en) | Modified ubiquitin regulatory system | |
DE69637628D1 (en) | EPISOMAL VECTOR AND ITS USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |